KCNH1 and osteosarcoma: To address the potential effects of Eag1 silencing on tumor growth in vivo, we made a xenograft model of osteosarcoma on nude mice and treated the xenografts by intra-tumor injection of Ad5-Eag1-shRNA, Ad5-Control-shRNA and saline, respectively.